Novel F141L pre-S2 mutation in hepatitis B virus increases the risk of hepatocellular carcinoma in patients with chronic genotype C infections

Journal of Virology

Volumn 85, Issue 1, 2011, Pages 123-132

  Mun, Ho Suk ^a   Lee, Seoung Ae ^a   Kim, Hong ^a   Hwang, Eung Soo ^a   Kook, Yoon Hoh ^a   Kim, Bum Joon ^a  

^a Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN DEPENDENT KINASE 4; PROTEIN P21; PROTEIN P53;

ADULT; ARTICLE; COLONY FORMATION; CONTROLLED STUDY; FEMALE; GENE MUTATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR MECHANICS; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; RESTRICTION MAPPING;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, VIRAL; GENOTYPE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; MUTATION; PROTEIN PRECURSORS; RISK;

HEPATITIS B VIRUS;

EID: 78650041795     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01524-10     Document Type: Article

References (27)

1. Beasley, R. P., L. Y. Hwang, C. C. Lin, and C. S. Chien. 1981. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet 21:1129-1133.
2. Bock, C. T., H. L. Tillmann, H. J. Maschek, M. P. Manns, and C. Trautwein. 1997. A preS mutation isolated from a patient with chronic hepatitis B infection leads to virus retention and misassembly. Gastroenterology 113:1976-1982.
3. Brechot, C., D. Gozuacik, Y. Murakami, and P. Paterlini-Brechot. 2000. Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Semin. Cancer Biol. 10:211-231. (Pubitemid 30614221)
4. Bruix, J., A. Castells, J. Bosch, F. Feu, J. Fuster, J. C. Garcia-Pagan, J. Visa, C. Bru, and J. Rodés. 1996. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 111:1018-1022. (Pubitemid 26327605)
5. Bruix, J., M. Sherman, J. M. Llovet, M. Beaugrand, R. Lencioni, A. K. Burroughs, E. Christensen, L. Pagliaro, M. Colombo, and J. Rodés for the EASL Panel of Experts on HCC. 2001. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J. Hepatol. 35:421-430.
6. Caselmann, W. H., M. Meyer, A. S. Kekule, U. Lauer, P. H. Hofschneider, and R. Koshy. 1990. A trans-activator function is generated by integration of hepatitis B virus preS/S sequences in human hepatocellular carcinoma DNA. Proc. Natl. Acad. Sci. U. S. A. 87:2970-2974.
7. Chao, Y., Y. L. Shih, J. H. Chiu, G. Y. Chau, W. Y. Lui, W. K. Yang, S. D. Lee, and T. S. Huang. 1998. Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma. Cancer Res. 58:985-990.
8. Chisari, F. V., K. Klopchin, T. Moriyama, C. Pasquinelli, H. A. Dunsford, S. Sell, C. A. Pinkert, R. L. Brinster, and R. D. Palmiter. 1989. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59:1145-1156.
9. Di Lelio, A., C. Cestari, A. Lomazzi, and L. Beretta. 1989. Cirrhosis: diagnosis with sonographic study of the liver surface. Radiology 172:389-392. (Pubitemid 19184875)
10. el-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
11. Gottlieb, T. M., and M. Oren. 1996. p53 in growth control and neoplasia. Biochim. Biophys. Acta 1287:77-102.
12. Kao, J. H., and D. S. Chen. 2002. Global control of hepatitis B virus infection. Lancet Infect. Dis. 2:395-403.
13. Kim, H., Y. M. Jee, B. C. Song, J. W. Shin, S. H. Yang, H. S. Mun, H. J. Kim, E. J. Oh, J. H. Yoon, Y. J. Kim, H. S. Lee, E. S. Hwang, C. Y. Cha, Y. H. Kook, and B. J. Kim. 2007. Molecular epidemiology of hepatitis B virus (HBV) genotypes and serotypes in patients with chronic HBV infection in Korea. Intervirology 50:52-57.
14. Kim, H. J., J. H. Park, Y. Jee, S. A. Lee, H. Kim, B. C. Song, S. Yang, M. Lee, J. H. Yoon, Y. J. Kim, H. S. Lee, E. S. Hwang, Y. H. Kook, and B. J. Kim. 2008. Hepatitis B virus X mutations occurring naturally associated with clinical severity of liver disease among Korean patients with chronic genotype C infection. J. Med. Virol. 80:1337-1343.
15. King, K. L., and J. A. Cidlowski. 1998. Cell cycle regulation and apoptosis. Annu. Rev. Physiol. 60:601-617.
16. Reference deleted.
17. Lok, A. S., and B. J. McMahon. 2001. Chronic hepatitis B. Hepatology 34:1225-1241.
18. McMahon, B. J., W. L. Alward, D. B. Hall, W. L. Heyward, T. R. Bender, D. P. Francis, J. E. Maynard. 1985. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J. Infect. Dis. 151:599-603.
19. Mun, H. S., S. A. Lee, Y. Jee, H. Kim, J. H. Park, B. C. Song, J. H. Yoon, Y. J. Kim, H. S. Lee, J. W. Hyun, E. S. Hwang, Y. H. Kook, and B. J. Kim. 2008. The prevalence of hepatitis B virus preS deletions occurring naturally in Korean patients infected chronically with genotype C. J. Med. Virol. 80:1189-1194.
20. Orito, E., M. Mizokami, H. Sakugawa, K. Michitaka, K. Ishikawa, T. Ichida, T. Okanoue, H. Yotsuyanagi, and S. Iino, S. 2001. A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Hepatology 33:218-223.
21. Paterlini, P., J. F. Flejou, M. S. De Mitri, E. Pisi, D. Franco, and C. Brechot. 1995. Structure an expression of the cyclin A gene in human primary liver cancer. Correlation with flow cytometric parameters. J. Hepatol. 23:47-52.
22. Raimondo, G., L. Costantino, G. Caccamo, T. Pollicino, G. Squadrito, I. Cacciola, and S. Brancatelli. 2004. Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases. J. Hepatol. 40:515-519.
23. Song, B. C., H. Kim, S. H. Kim, C. Y. Cha, Y. H. Kook, and B. J. Kim. 2005. Comparison of full-length sequences of hepatitis B virus isolates in hepatocellular carcinoma patients and asymptomatic carriers of Korea. J. Med. Virol. 75:13-19.
24. Song, B. C., S. H. Kim, H. Kim, Y. H. Ying, H. J. Kim, Y. J. Kim, J. H. Yoon, H. S. Lee, C. Y. Cha, Y. H. Kook, and B. J. Kim. 2005. Prevalence of naturally occurring surface antigen variants of hepatitis B virus in Korean patients infected chronically. J. Med. Virol. 76:194-202.
25. Trautwein, C., H. Schrem, H. L. Tillmann, S. Kubicka, D. Walker, K. H. Böker, H. J. Maschek, R. Pichlmayr, and M. P. Manns. 1996. Hepatitis B virus mutations in the pre-S genome before and after liver transplantation. Hepatology 24:482-488.
26. Wang, H. C., W. Huang, M. D. Lai, and I. J. Su. 2006. Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Cancer Sci. 97:683-688.
27. Yoo, B. C., J. W. Park, H. J. Kim, D. H. Lee, Y. J. Cha, and S. M. Park. 2003. Precore and core promoter mutations of hepatitis B virus and hepatitis B e antigen-negative chronic hepatitis B in Korea. J. Hepatol. 38:98-103.